tiprankstipranks
Advertisement
Advertisement

ABT Stock Latest News

Analyst Raises Abbott Price Target to $135 on Strengthening Cancer Diagnostics Growth and Successful Exact Sciences Integration
RatingsAnalyst Raises Abbott Price Target to $135 on Strengthening Cancer Diagnostics Growth and Successful Exact Sciences Integration
3d ago
ABT
Abbott settles major preterm formula litigation claims
PremiumCompany Announcements
Abbott settles major preterm formula litigation claims
3d ago
8K
ABT
Abbott resolves portion of litigation regarding specialty infant formulas
PremiumThe Fly
Abbott resolves portion of litigation regarding specialty infant formulas
3d ago
ABT
HealthTab enters collaboration agreement with Abbott
PremiumThe Fly
HealthTab enters collaboration agreement with Abbott
4d ago
ABT
MiniMed announces Flex system shipping in the U.S. with Instinct sensor
PremiumThe Fly
MiniMed announces Flex system shipping in the U.S. with Instinct sensor
7d ago
ABT
MMED
Reckitt Benckiser’s Mead Johnson faces first bellwether trial over Enfamil
PremiumThe FlyReckitt Benckiser’s Mead Johnson faces first bellwether trial over Enfamil
7d ago
ABT
Abbott upgraded to Outperform from Peer Perform at Wolfe Research
Premium
The Fly
Abbott upgraded to Outperform from Peer Perform at Wolfe Research
7d ago
ABT
Wolfe upgrades Abbott to Outperform on 2027 growth pickup
Premium
The Fly
Wolfe upgrades Abbott to Outperform on 2027 growth pickup
7d ago
ABT
Abbott price target raised to $125 from $112 at Citi
PremiumThe Fly
Abbott price target raised to $125 from $112 at Citi
7d ago
ABT
Enphase, Opendoor, Abbott, Take-Two, Nasdaq Insider Shocks
PremiumWeekend Updates
Enphase, Opendoor, Abbott, Take-Two, Nasdaq Insider Shocks
9d ago
ABT
ENPH
Court Dismisses Amended Securities Complaint Against Abbott Laboratories 
PremiumClass Action
Court Dismisses Amended Securities Complaint Against Abbott Laboratories 
9d ago
ABT
Early AF Treatment on Trial: What Abbott’s PULSE Study Could Mean for Investors
PremiumCompany Announcements
Early AF Treatment on Trial: What Abbott’s PULSE Study Could Mean for Investors
11d ago
ABT
SCHD vs. VYMI vs. VIG: Which Is the Best Dividend ETF for Passive Income Investors?
PremiumMarket NewsSCHD vs. VYMI vs. VIG: Which Is the Best Dividend ETF for Passive Income Investors?
12d ago
HD
ABT
Abbott and Google launch partnership for glucose insights and AI coaching
Premium
The Fly
Abbott and Google launch partnership for glucose insights and AI coaching
13d ago
ABT
GOOG
Here’s Why These 3 ETFs Are Beating the S&P 500 Index in 2026
Premium
Market News
Here’s Why These 3 ETFs Are Beating the S&P 500 Index in 2026
21d ago
KO
ABT
3 ‘Strong Buy’ Dividend Aristocrat Stocks to Power Your Cash Flow, 7/30/26
PremiumMarket News
3 ‘Strong Buy’ Dividend Aristocrat Stocks to Power Your Cash Flow, 7/30/26
24d ago
ABT
LIN
SCHD vs. VYMI: Which Dividend ETF Comes Out on Top?
PremiumMarket News
SCHD vs. VYMI: Which Dividend ETF Comes Out on Top?
24d ago
ABT
MRK
Abbott Laboratories: Buy Rating Backed by Strengthening Nutrition Franchise and 2026 Growth Drivers
PremiumRatings
Abbott Laboratories: Buy Rating Backed by Strengthening Nutrition Franchise and 2026 Growth Drivers
26d ago
ABT
Abbott price target lowered to $125 from $135 at UBS
PremiumThe Fly
Abbott price target lowered to $125 from $135 at UBS
27d ago
ABT
Freenome, Abbott announce FDA approval of SimpleScreen CRC
PremiumThe FlyFreenome, Abbott announce FDA approval of SimpleScreen CRC
28d ago
ABT
FRNM
VYMI vs. SCHD: Which Is the Best Dividend ETF for Passive Income?
Premium
Market News
VYMI vs. SCHD: Which Is the Best Dividend ETF for Passive Income?
1M ago
ABT
MRK
Abbott price target raised to $115 from $102 at BofA
Premium
The Fly
Abbott price target raised to $115 from $102 at BofA
1M ago
ABT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >